| Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among … RM Emanuel, AC Dueck, HL Geyer, JJ Kiladjian, S Slot, S Zweegman, ... Journal of clinical oncology 30 (33), 4098-4103, 2012 | 556 | 2012 |
| The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients R Scherber, AC Dueck, P Johansson, T Barbui, G Barosi, AM Vannucchi, ... Blood, The Journal of the American Society of Hematology 118 (2), 401-408, 2011 | 431 | 2011 |
| Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide CN Harrison, AJ Mead, A Panchal, S Fox, C Yap, E Gbandi, A Houlton, ... Blood, The Journal of the American Society of Hematology 130 (17), 1889-1897, 2017 | 174 | 2017 |
| Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2 (V617F) inhibitor, in patients with myelofibrosis RS Komrokji, JF Seymour, AW Roberts, M Wadleigh, LB To, R Scherber, ... Blood, The Journal of the American Society of Hematology 125 (17), 2649-2655, 2015 | 147 | 2015 |
| Cognitive enhancement drug use among future physicians: Findings from a multi-institutional census of medical students RM Emanuel, SL Frellsen, KJ Kashima, SM Sanguino, FS Sierles, ... Journal of general internal medicine 28, 1028-1034, 2013 | 144 | 2013 |
| Impact of inflammation on myeloproliferative neoplasm symptom development HL Geyer, AC Dueck, RM Scherber, RA Mesa Mediators of Inflammation 2015 (1), 284706, 2015 | 133 | 2015 |
| Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients HL Geyer, RM Scherber, AC Dueck, JJ Kiladjian, Z Xiao, S Slot, ... Blood, The Journal of the American Society of Hematology 123 (24), 3803-3810, 2014 | 122 | 2014 |
| The critical role of inflammation in the pathogenesis and progression of myeloid malignancies BM Craver, K El Alaoui, RM Scherber, AG Fleischman Cancers 10 (4), 104, 2018 | 112 | 2018 |
| How we diagnose and treat systemic mastocytosis in adults RM Scherber, U Borate British journal of haematology 180 (1), 11-23, 2018 | 96 | 2018 |
| Symptomatic profiles of patients with polycythemia vera: implications of inadequately controlled disease H Geyer, R Scherber, H Kosiorek, AC Dueck, JJ Kiladjian, Z Xiao, S Slot, ... Journal of Clinical Oncology 34 (2), 151-159, 2016 | 87 | 2016 |
| Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo (a) pyrene–induced lung tumorigenesis in A/J mice and modulates carcinogen-induced … F Kassie, LB Anderson, R Scherber, N Yu, D Lahti, P Upadhyaya, ... Cancer Research 67 (13), 6502-6511, 2007 | 87 | 2007 |
| Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms P Johansson, R Mesa, R Scherber, J Abelsson, J Samuelsson, ... Leukemia & lymphoma 53 (3), 441-444, 2012 | 81 | 2012 |
| Comprehensively understanding fatigue in patients with myeloproliferative neoplasms RM Scherber, HE Kosiorek, Z Senyak, AC Dueck, MM Clark, MA Boxer, ... Cancer 122 (3), 477-485, 2016 | 79 | 2016 |
| Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis L Ronner, N Podoltsev, J Gotlib, ML Heaney, AT Kuykendall, C O’Connell, ... Blood, The Journal of the American Society of Hematology 135 (19), 1696-1703, 2020 | 75 | 2020 |
| Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms J Abelsson, B Andréasson, J Samuelsson, M Hultcrantz, E Ejerblad, ... Leukemia & lymphoma 54 (10), 2226-2230, 2013 | 75 | 2013 |
| Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group HL Geyer, H Kosiorek, AC Dueck, R Scherber, S Slot, S Zweegman, ... Haematologica 102 (1), 85, 2017 | 67 | 2017 |
| Support needs of overweight African American women for weight loss JL Thomas, DW Stewart, IM Lynam, CM Daley, C Befort, RM Scherber, ... American journal of health behavior 33 (4), 339-352, 2009 | 55 | 2009 |
| Changes in the incidence and overall survival of patients with myeloproliferative neoplasms between 2002 and 2016 in the United States S Verstovsek, J Yu, RM Scherber, S Verma, C Dieyi, CC Chen, ... Leukemia & Lymphoma 63 (3), 694-702, 2022 | 46 | 2022 |
| Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls LA Anderson, G James, AS Duncombe, R Mesa, R Scherber, AC Dueck, ... American journal of hematology 90 (10), 864-870, 2015 | 46 | 2015 |
| Avapritinib versus placebo in indolent systemic mastocytosis J Gotlib, M Castells, HO Elberink, F Siebenhaar, K Hartmann, ... NEJM evidence 2 (6), EVIDoa2200339, 2023 | 42 | 2023 |
